SV Health Investors
Venture capitalBoston · Pre-Seed–Late Stage · 4 people tracked
Investment thesis
SV Health Investors backs diverse entrepreneurs building breakthrough healthcare and life sciences companies across biotechnology, medtech, and healthcare growth equity. The firm combines over 30 years of investment experience in the US and UK with a team of more than 50 investment professionals and operating partners to guide portfolio companies toward successful exits via strategic acquisition or public offering, while delivering improved patient outcomes and shareholder returns.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websiteInvestments · showing 60 of 200
founders shown can be your intro pathClinical-stage company developing novel treatment for recurrent high-grade gliomas
Developer of RejuvenAir® System for airway remodeling treatment
Frequently asked questions
- What stage does SV Health Investors invest at?
- SV Health Investors invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does SV Health Investors focus on?
- SV Health Investors focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is SV Health Investors located?
- SV Health Investors is headquartered in Boston, US.
- Does SV Health Investors lead rounds?
- Yes, SV Health Investors leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Novo Holdings is a holding and investment company managing the assets of the Novo Nordisk Foundation, one of the world's largest enterprise foundations. The firm invests in life science companies across all development stages and manages a diversified portfolio including equities, bonds, real estate, infrastructure, and private equity.
Apple Tree Partners is a life sciences venture capital firm that creates and builds transformative biotechnology companies from early-stage science through public markets. The firm works with scientists at various stages, from pre-IP ideas to company spinouts, providing capital, strategic guidance, and operational resources.
Ambix invests in medical devices, biochemistry-based technologies, and digital health solutions addressing unmet healthcare needs, supporting companies from early-stage startups through later-stage commercial expansion.